Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis

Emmanuel Roilides, Tin Sein, Robert Schaufele, Stephen J. Chanock, Thomas J. Walsh

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Hepatosplenic candidiasis (HSC) becomes clinically overt in cancer patients upon recovery from neutropenia. HSC may be a consequence of a Th1- Th2 imbalance, characterized by increased serum levels of one or more cytokines. Serum levels of two immunosuppressive cytokines, markers of the Th2 pathway, interleukin (IL)-4 and IL-10 were measured by ELISA in 10 patients with HSC (22 samples) and compared with 19 healthy blood donors, 13 patients with cancer but no infection (23 samples), and 11 patients with cancer and various bacterial infections (17 samples). IL-4 was undetectable in all controls and patients. By contrast, levels of IL-10 were increased in HSC patients compared with levels in healthy donors and cancer patients without infection (P < .001) or with bacterial infections (P < .01). These findings indicate that IL-10 but not IL-4 is increased in patients with HSC and suggest that IL-10 plays a role in the pathogenesis of this infection.

Original languageEnglish (US)
Pages (from-to)589-592
Number of pages4
JournalJournal of Infectious Diseases
Issue number2
StatePublished - 1998
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis'. Together they form a unique fingerprint.

Cite this